Policy paper: Cannabis-based products for medicinal use in humans: commission to the ACMD


The Home Secretary has formally commissioned the Advisory Council on the Misuse of Drugs (ACMD) to conduct a longer-term review of cannabis-based products for medicinal use.

The ACMD issued their short-term advice on 19 July and 11 September with a set of recommendations for both the Home Office and the Department of Health and Social Care (DHSC). On 1 November, cannabis-based products for medicinal use were added to Schedule 2 under the 2001 Regulations.


Ga naar Bron